TORONTO–(BUSINESS WIRE)–BioConnect is proud to announce that the latest release of BioConnect Enterprise 5.1 software and BioConnect Link 1.4.2 will be available by July 2022 as part of its Trust Platform.
Over the next three years, most companies will operate in jurisdictions that require obtaining user consent before performing biometric enrollment, following the example of Europe (General Data Protection Regulation, GDPR), Illinois (Biometric Information Privacy Act, BIPA), Texas (Capture or Use of Biometric Identifiers Act, CUBI), and California (California Consumer Privacy Act of 2018, CCPA). Point-to-point biometric integrations Traditional point can easily create gaps in companies’ operational controls that could lead to violations and hefty fines. To help comply with privacy legislation in the context of biometric identifiers in various regions of the world, the BioConnect Trust Platform enables organizations to capture user consent to enroll biometric data digitally ensuring irrefutable audit trail.
For the past 12 years, with the award-winning BioConnect Enterprise Software, organizations have easily been able to add biometric devices to their existing physical access control solutions and integrate all locations, users and devices into a single platform. Recognized as the highest level of security available to protect organizations from physical access breaches on a single, comprehensive platform, the 5.1 upgrade will include high-demand features such as: user consent tracking, user import via Excel, OSDP support for Gen 2 Suprema devices, two-person authentication, user imports via Excel, and alerts for ‘doors held open’ and ‘forced open’ doors.
“We are excited to announce the launch of our next generation BioConnect Enterprise and BioConnect Link scheduled for July 2022. This is the most significant upgrade we have ever undertaken and our customers, partners and the BioConnect community will benefit the most advanced and secure security platform on the market. It is a considerable development of the BioConnect Trust Platform. »Rob Douglas, CEO and President, BioConnect.
Another key component of the Trust Platform, BioConnect Link, offers innovative solutions for various authentication needs focused on small spaces. Utilizing adaptive authentication through existing trusted mobile authenticators, such as Cisco/Duo, Okta, PingID, and BioConnect mobile and its built-in HID Mobile credential capability, Link delivers a single, elevated credential experience for physical access, without replacing the drive infrastructure. Link 1.4.2 continues this trend by seeking to be above all a complete solution for accessing in small spaces through standalone Key and Safe Cabinet solutions based on BioConnect’s reliable enterprise-grade security, smart user experience, live alerts, and more. real-time and robustness that provide layers of redundancy to ensure access authentication is unaffected, even while offline.
The BioConnect Trust Platform is designed for large enterprises with complex large-scale infrastructures. This new update will be available in July 2022. Please join BioConnect on June 15, 12:00-17:00 EDT, to attend its annual virtual Customer Symposium. Register now for your favorite session.
The text of the press release resulting from a translation should in no way be considered official. The only authentic version of the press release is that of the press release in its original language. The translation will always have to be compared with the source text, which will set a precedent.
We wish to say thanks to the author of this article for this amazing web content
BioConnect will release the next generation of its Trust Platform featuring an expanded set of new features that, among other things, make it easier for companies to comply with GDPR, BIPA, CCPA and CUBI
Check out our social media accounts as well as other pages that are related to them.https://yaroos.com/related-pages/